Post COVID-19 Condition (PCC)DB-PCCNCT06776263
Dysfunctional Breathing in Post COVID-19 Condition.
An observational study of Post COVID-19 Condition (PCC) and Dysfunctional Breathing, run by Karolinska Institutet at 2 sites in Sweden.
Trial summary
The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Post COVID-19 Condition (PCC), Dysfunctional Breathing, Breathing Pattern Disorder
- How many people
- 200 participants
- Where
- 2 sitesSweden
- Study dates
- 15 Jan 2025to 30 Jun 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be > 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing)
Who may be able to join
- Patients that state that they have persistent respiratory problems, have 2 or higher on mMRC scale or 23 and over on the Nijmegen scale will be included.
Who cannot join
- Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden2 sites, 2 recruiting
- Recruiting
Karolinska Institutet
Huddinge, 14183
- Not yet recruiting
Karolinska University Hospital
Stockholm, Solna, 17176
Malin Nygren Bonnier, PhD
About this study
Official title: Dysfunctional Breathing in Patients With Post COVID-19 Condition
The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition. The main question aims to answer which measurements can identify and asses dysfunctional breathing in patients with post COVID-19 condition?
Participants for this study will be recruited from the ReCov cohort will be evaluated with diffrent measurments and questionnaires.
Read the detailed description
The overall aim with the proposed research project is to describe and investigate the underlying mechanisms of dysfunctional breathing and the experience of living with dysfunctional breathing in patients with post-COVID-19 conditions. In addition, validate and evaluate which methods measure dysfunctional breathing regarding content validity, conceptual validity, test-retest reliability, and sensitivity to change for patients with post-COVID-19 conditions. Furthermore, to develop and evaluate an individually adapted intervention with the aim of normalizing the breathing pattern. In the next step, to evaluate the effects of an individually adapted intervention on physical and psychological function and health-related quality of life (HRQoL) in patients with post-COVID-19 conditions, as well as to describe the patients' experiences of rehabilitation.
Methods and planned studies This project is a part of a larger multi-disciplinary and multi-professional study, ReCOV, that takes a holistic perspective on the consequences of the disease. ReCOV is a three-armed project including patients, next of kin and staff (23). Patients have been followed up at the out-patient clinic for patients with PCC at Karolinska University Hospital (K).
The longitudinal observational study is about physical and psychological recovery, objectively measured physical activity and also an interview study of the patients' overall experiences of rehabilitation after COVID-19 both in the acute and long-term perspective. In total approximately 950 patients have accepted to be apart of ReCOV and to this proposed project patients will be recruited from this cohort but also from primary care. This research project will be performed in collaboration with Karolinska Institutet, Karolinska university Hospital (K), Sahlgrenska University Hospital (SH). University of Gothenburg and primary care in Region Stockholm.
Study 1: Dysfunctional breathing in patients with post COVID-19 condition?
Aim: To investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition.
Design: Cross-sectional design
Participants: Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be > 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing). Exclusion Criteria: Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.
Procedure and outcomes: All included patients will be evaluated for physical and psychological function, symptoms and HrQoL. The following measurements and questionnaires will be used:
Dependent variables (primary outcome):
Health-related Quality of Life (EQ-5D-5L), EQ VAS Breathing pattern by Respiratory Movement Measuring Instrument (RMMI)
Independent, confounding and possible moderating variables:
Inspiratory and expiratory muscle strength (MIP and MEP) (Micro-RPM) Chest mobility by thoracic expansion Six-minute walk to measure endurance (in meters) Spirometry Diaphragmatic ultrasound End tidal CO2 measured during exercise
Physical Activity level (Frändin/ Grimby) Nijmegen questionnaire (dysfunctional breathing) COPD Assessment Test (CAT), questionnaire of symptoms related to breathing and now commonly used for this group of patients Dyspnea (mMRC, Modified Medical Research Council, Dyspnea Scale and BORG CR10) Patient Health Questionnaire (PHQ-9) Generalized Anxiety Disorder 7-item scale (GAD-7) Breathing Pattern Assessment Tool (BPAT)
- Conditions
- Post COVID-19 Condition (PCC), Dysfunctional Breathing, Breathing Pattern Disorder, Post-Acute COVID-19 Syndrome
- Keywords
- Respiration, Dyspnea, Signs and Symptoms, Respiratory, Hyperventilation, Outcome Assessment, Health Care, Patient Outcome Assessment, Surveys and Questionnaires
- Medical subject headings
- Post-Acute COVID-19 Syndrome, Respiratory Aspiration, Dyspnea, Signs and Symptoms, Respiratory, Hyperventilation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients with post COVID-19 condition. | Patients with post COVID-19 condition and respiratory problems. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Breathing pattern by Respiratory Movement Measuring Instrument (RMMI) and Health-related Quality of Life (EQ-5D-5L)
Will be assesed in a supine position, using the RMMI. First, during 30 seconds of tidal volume breathing. Second, during 60 seconds of performing maximal breathing manoeuvres interspaced by tidal volume breathing and then during 60 seconds after performing activity that triggers dyspnea. The RMMI records bilateral changes in the anterior posterior diameter, including both upper and lower thoracic and abdominal movements.
Health-related Quality of Life is measured with EuroQualityOf Life 5 dimensions questionnaire (EQ-5D-5L), which is an instrument that evaluates the generic quality of life. EQ-5D includes a descriptive system, which comprises 5 dimensions of health: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression. A descriptive index-score between 0-1, higher score indicates higher HRQoL. EQ-5D also includes a visual analog scale (VAS), which records self-rated health status on a graduated (0-100) scale, with higher scores for higher HRQoL
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Secondary outcomes (17)
Maximal Inspiratory Pressure (MIP)
Maximal Inspiratory muscle strength (MIP) will be measured with Micro RPM in cmH2O
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Maximal Expiratory Pressure ( MEP)
Maximal expiratory muscle strength (MEP) will be measured with Micro-RPM in cm H20
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Chest mobility
Chest mobility will be measured with a tape measure at the xiphoid process and the 4th rib
Measured: Assessment will be applied only once and takes about 5 minutes to be completed.
Six-minute walk test (6MWT)
Six-minute walk to measure endurance (in meters)
Measured: Assessment will be applied only once and takes about 15 minutes to be completed.
Spirometry
Lung function test with forced vital capacity (FVC), forced expiratory flow in one second (FEV1), diffusion capacity (DLCO)
Measured: Assessment will be applied only once and takes about 30 minutes to be completed.
End tidal CO2
End tidal CO2 measured during exercise
Measured: Assessment will be applied only once and takes about 15 minutes to be completed.
Physical Activity level (Frändin/ Grimby)
Measured with Frändin/Grimby activity scale, which is a self-assessment scale about current levels of physical activity, ranging from 1 to 6. The higher the score, the higher level of physical activity.
Measured: Assessment will be applied only once and takes about 2 minutes to be completed.
Nijmegen questionnaire (dysfunctional breathing)
Dysfunctional breathing will be assessed with the Nijmegen questionnaire. The questionnaire consists of 16 items asking about the symptoms related to dysfunctional breathing.
Participants will grade how often they suffered from each item on a five-point Likert scale, ranging from 0 to 4, in which 0 is never ,1 is rarely, 2 is sometimes , 3 is often , and 4 is very often. Total score ranging from 0 to 64. A score of 23 and over indicates dysfunctional breathing.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
COPD Assessment Test (CAT)
COPD Assessment Test (CAT), questionnaire of symptoms related to breathing and now commonly used for this group of patients. COPD Total score ranging from 0 to 40, where a higher number indicates more symptoms
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Dyspnea
Dyspnea (mMRC, Modified Medical Research Council 0-4), Dyspnea Scale and BORG CR10).
Modified Medical Research Council (mMRC), which is a self-rating tool to measure the degree of disability that breathlessness postures on daily physical activities on a scale from 0 to 4. 0, no breathlessness except on strenuous exercise; 1, shortness of breath when hurrying on the level or walking up a hill; 2, walks slower than people of same age on the level because of breathlessness; 3, stops for breath when walking at their own pace on the level; and 4, Breathless when washing or getting dressed.
Borg CR-10 ranging between 0-10. The higher the score, the higher the dyspnea.
Measured: Assessment will be applied only once and takes about 5 minutes to be completed.
Depression
Depression will be assessed with the Patient Health Questionnaire (PHQ-9). PHQ-9 which contains 9 items. Total score ranges from 0 to 27. Higher score indicate more severe depression symptoms
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Anxiety
Anxiety will be assessed with the Generalized Anxiety Disorder 7-item scale (GAD-7) which is a self assessment tool. Total score ranging from 0-21. Higher score indicates higher anxiety.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Breathing Pattern
The Brompton BPAT (BREATHING PATTERN ASSESSMENT TOOL) will be used. Assessment components include (i) evaluation of chest/abdominal wall movement, noise of (ii) inspiratory and (iii) expiratory flow, (iv) channel of inspiration and expiration, (v) signs of air hunger (yawning, sighing and deeper breaths), (vi) RR and (vii) rhythm. Each component is given a score from 0 to 2, based on features consistent with expected normal (0) versus that present in severe dysfunctional breathing (2), giving a total score of between 0 and 14. The BPAT is completed with a patient positioned, as per the standard assessment of resting breathing pattern (i.e. sat comfortably in a supported seat for at least 5 min) and takes approximately 1 min to collate.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Thickness of the diaphragm
The thickness of the diaphragm will be measured using ultrasound at end-inspiration and end-expiration and is presented in cm.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Movement of the diaphragm
The movement of the diaphragm at rest, at deep breathing and at sniff manuver will be measured using ultrasound and presented in cm.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Velocity of the diaphragm
The velocity of the diaphragm movment will be measured with ultra sound and presented as cm/s.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Thickening fraction of the diaphragm
The thickening fraction of the diaphragm will be measured using ultrasound and is calculated using a formula, thickening fraction=(end-inspiration - end-expration)/ end-expiraton ×100%. Measurements are performed 3 times and the average value is calculated and presented.
Measured: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2025
- Study start15 Jan 2025
- Primary completion31 Dec 2025 (estimated)
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post COVID-19 Condition (PCC)Studies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Collaborators
- Karolinska University Hospital
- Responsible party
- Principal investigator, Malin Nygren-Bonnier, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06776263
- Sponsor's protocol ID
- 2024-05930-01
- Acronym
- DB-PCC
- Status last verified
- Feb 2025
- First submitted
- 13 Jan 2025
- Last updated
- 14 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dysfunctional Breathing in Patients With Post COVID-19 Condition
- ClinicalTrials.gov ID
- NCT06776263
- Acronym / sponsor ID
- DB-PCC / 2024-05930-01
- Conditions
- Post COVID-19 Condition (PCC), Dysfunctional Breathing, Breathing Pattern Disorder, Post-Acute COVID-19 Syndrome
- Keywords
- Respiration, Dyspnea, Signs and Symptoms, Respiratory, Hyperventilation, Outcome Assessment, Health Care, Patient Outcome Assessment, Surveys and Questionnaires
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Collaborators
- Karolinska University Hospital
- Study start
- 15 Jan 2025 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 15 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition. The main question aims to answer which measurements can identify and asses dysfunctional breathing in patients with post COVID-19 condition?
Participants for this study will be recruited from the ReCov cohort will be evaluated with diffrent measurments and questionnaires.
Detailed description
The overall aim with the proposed research project is to describe and investigate the underlying mechanisms of dysfunctional breathing and the experience of living with dysfunctional breathing in patients with post-COVID-19 conditions. In addition, validate and evaluate which methods measure dysfunctional breathing regarding content validity, conceptual validity, test-retest reliability, and sensitivity to change for patients with post-COVID-19 conditions. Furthermore, to develop and evaluate an individually adapted intervention with the aim of normalizing the breathing pattern. In the next step, to evaluate the effects of an individually adapted intervention on physical and psychological function and health-related quality of life (HRQoL) in patients with post-COVID-19 conditions, as well as to describe the patients' experiences of rehabilitation.
Methods and planned studies This project is a part of a larger multi-disciplinary and multi-professional study, ReCOV, that takes a holistic perspective on the consequences of the disease. ReCOV is a three-armed project including patients, next of kin and staff (23). Patients have been followed up at the out-patient clinic for patients with PCC at Karolinska University Hospital (K).
The longitudinal observational study is about physical and psychological recovery, objectively measured physical activity and also an interview study of the patients' overall experiences of rehabilitation after COVID-19 both in the acute and long-term perspective. In total approximately 950 patients have accepted to be apart of ReCOV and to this proposed project patients will be recruited from this cohort but also from primary care. This research project will be performed in collaboration with Karolinska Institutet, Karolinska university Hospital (K), Sahlgrenska University Hospital (SH). University of Gothenburg and primary care in Region Stockholm.
Study 1: Dysfunctional breathing in patients with post COVID-19 condition?
Aim: To investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition.
Design: Cross-sectional design
Participants: Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be > 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing). Exclusion Criteria: Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.
Procedure and outcomes: All included patients will be evaluated for physical and psychological function, symptoms and HrQoL. The following measurements and questionnaires will be used:
Dependent variables (primary outcome):
Health-related Quality of Life (EQ-5D-5L), EQ VAS Breathing pattern by Respiratory Movement Measuring Instrument (RMMI)
Independent, confounding and possible moderating variables:
Inspiratory and expiratory muscle strength (MIP and MEP) (Micro-RPM) Chest mobility by thoracic expansion Six-minute walk to measure endurance (in meters) Spirometry Diaphragmatic ultrasound End tidal CO2 measured during exercise
Physical Activity level (Frändin/ Grimby) Nijmegen questionnaire (dysfunctional breathing) COPD Assessment Test (CAT), questionnaire of symptoms related to breathing and now commonly used for this group of patients Dyspnea (mMRC, Modified Medical Research Council, Dyspnea Scale and BORG CR10) Patient Health Questionnaire (PHQ-9) Generalized Anxiety Disorder 7-item scale (GAD-7) Breathing Pattern Assessment Tool (BPAT)
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients with post COVID-19 condition. | – | –Patients with post COVID-19 condition and respiratory problems. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients (approximately n=200) for this study will be recruited from the ReCov cohort. All patients will be > 18 years old. Patients that state that they have persistent respiratory problems and abnormal clinical respiratory findings will be included. Patients will also be recruited from primary care if they have suspected dysfunctional breathing pattern (unable to breathe with a normal breathing pattern in standing)
Key inclusion criteria (1 listed)
- Patients that state that they have persistent respiratory problems, have 2 or higher on mMRC scale or 23 and over on the Nijmegen scale will be included.
Key exclusion criteria (1 listed)
- Not able to perform the measurements because of cognitive or physical impairments, ongoing intervention of breathing exercises.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Breathing pattern by Respiratory Movement Measuring Instrument (RMMI) and Health-related Quality of Life (EQ-5D-5L)
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Will be assesed in a supine position, using the RMMI. First, during 30 seconds of tidal volume breathing. Second, during 60 seconds of performing maximal breathing manoeuvres interspaced by tidal volume breathing and then during 60 seconds after performing activity that triggers dyspnea. The RMMI records bilateral changes in the anterior posterior diameter, including both upper and lower thoracic and abdominal movements. Health-related Quality of Life is measured with EuroQualityOf Life 5 dimensions questionnaire (EQ-5D-5L), which is an instrument that evaluates the generic quality of life. EQ-5D includes a descriptive system, which comprises 5 dimensions of health: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression. A descriptive index-score between 0-1, higher score indicates higher HRQoL. EQ-5D also includes a visual analog scale (VAS), which records self-rated health status on a graduated (0-100) scale, with higher scores for higher HRQoL
17 secondary outcomes
Maximal Inspiratory Pressure (MIP)
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Maximal Expiratory Pressure ( MEP)
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Chest mobility
Time frame: Assessment will be applied only once and takes about 5 minutes to be completed.
Six-minute walk test (6MWT)
Time frame: Assessment will be applied only once and takes about 15 minutes to be completed.
Spirometry
Time frame: Assessment will be applied only once and takes about 30 minutes to be completed.
End tidal CO2
Time frame: Assessment will be applied only once and takes about 15 minutes to be completed.
Physical Activity level (Frändin/ Grimby)
Time frame: Assessment will be applied only once and takes about 2 minutes to be completed.
Nijmegen questionnaire (dysfunctional breathing)
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
COPD Assessment Test (CAT)
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Dyspnea
Time frame: Assessment will be applied only once and takes about 5 minutes to be completed.
Depression
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Anxiety
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Breathing Pattern
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Thickness of the diaphragm
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Movement of the diaphragm
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Velocity of the diaphragm
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Thickening fraction of the diaphragm
Time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Feb 2025.
- Related InfoLink provided by the sponsor.
Related trials for Post COVID-19 Condition (PCC)
Not yet recruitingPhase 2
CD19-B Cell Depletion in PAIS-ME/CFS Patients
Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID)
Not yet recruitingPhase 2
Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)
Post-acute Infectious Syndrome (PAIS), Post-COVID-19 Condition (PCC or Long COVID)
Active, not recruitingPhase 2
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
Post-COVID Condition, Fatigue Symptom
Recruiting
Brain Stimulation in Long COVID
Long COVID, PASC Post Acute Sequelae of COVID 19
Enrolling by invitationPhase 3
RECLAIM Adaptive Platform Trial for PCC Treatments
Post COVID Condition
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Post COVID-19 Condition (PCC) and Dysfunctional Breathing, run by Karolinska Institutet at 2 sites in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Malin Nygren-Bonnier, Associate professor, PhD (+46852488831, malin.nygren-bonnier@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Breathing pattern by Respiratory Movement Measuring Instrument (RMMI) and Health-related Quality of Life (EQ-5D-5L) (time frame: Assessment will be applied only once and takes about 5-10 minutes to be completed.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2025.